Biogen (BIIB) EBITDA Margin (2009 - 2026)
Biogen (BIIB) recorded quarterly EBITDA Margin of 11.43% in Q1 2026, up 52.74% quarter-over-quarter from 24.19% in Q4 2025, and up 165.0% on a YoY basis from 4.31% in Q1 2025.
Biogen (BIIB) EBITDA Margin (2009 - 2026) Analysis & Trends
Biogen's EBITDA Margin history runs 18 years deep, the most recent figure standing at 11.43% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 165.0% year-over-year to 11.43%; the TTM figure through Mar 2026 stood at 8.18% (down 161.0% YoY), while the FY2025 annual figure was 8.57%, down 439.0% from the prior year.
- EBITDA Margin was 11.43% for Q1 2026 at Biogen, up from 24.19% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 35.94% in Q3 2022 to a low of 31.65% in Q3 2023.
- Historically, EBITDA Margin has averaged 0.72% across 5 years, with a median of 3.38% in 2024.
- The sharpest annual moves came in 2023 and 2024: EBITDA Margin plunged 6759 bps in 2023, then surged 2404 bps in 2024.
- A 5-year view of EBITDA Margin shows it stood at 17.29% in 2022, then slumped by 69 bps to 5.35% in 2023, then tumbled by 322 bps to 11.9% in 2024, then slumped by 103 bps to 24.19% in 2025, then soared by 53 bps to 11.43% in 2026.
- The last three EBITDA Margin figures came in at 11.43% (Q1 2026), 24.19% (Q4 2025), and 4.62% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 30.06% |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 47.98% |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 26.44% |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 26.60% |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | -47.46% |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 30.94% |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 37.16% |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | -286.83% |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 24.65% |
| 10 | Biogen | 28.75 Bn | 24.47 Bn | 1.82 Bn | -11.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.43% |
| Dec 31, 2025 | -24.19% |
| Sep 30, 2025 | -4.62% |
| Jun 30, 2025 | 5.25% |
| Mar 31, 2025 | -13.09% |
| Dec 31, 2024 | -11.90% |
| Sep 30, 2024 | -7.61% |
| Jun 30, 2024 | 6.19% |
| Mar 31, 2024 | -3.38% |
| Dec 31, 2023 | 5.35% |
| Sep 30, 2023 | -31.65% |
| Jun 30, 2023 | 4.70% |
| Mar 31, 2023 | -9.11% |
| Dec 31, 2022 | 17.29% |
| Sep 30, 2022 | 35.94% |
| Jun 30, 2022 | 30.34% |
| Mar 31, 2022 | 24.12% |
| Dec 31, 2021 | 21.48% |
| Sep 30, 2021 | 28.57% |
| Jun 30, 2021 | 17.50% |